Recharging the Human Battery
BioLight is "recharging the human battery" using the power of red-light therapy.
Perhaps surprisingly, 80% of modern diseases are tied to the same affliction: dysfunctional mitochondria.
This condition happens when our body’s cells don’t get enough natural sunlight. These days, with everyone spending most of their time indoors, surrounded by non-native, “fake” light, that’s a common occurrence.
The good news is that mitochondrial health can be improved using red light therapy, an innovative technique that uses red and near-infrared (NIR) wavelengths to promote health, wellness, and longevity.
BioLight is focusing on this type of therapy with a line of personal red and NIR light devices.
This company is growing fast. In 2019, its revenues were less than $5,000. In 2020, annual revenues reached $344,000. And through July of this year, revenue had already hit more than $500,000.
BioLight has two patents covering its products, and expects to reach 10 patents by the end of this year.
Note: BioLight is "Testing the Waters." That means you can reserve a spot now to ensure you can invest in the company when it opens its official campaign. Reservations are non-binding, so there is no risk in making a reservation.